Immix Biopharma, Inc. (IMMX)
Immix Biopharma Market Cap : 626.92M for Nov. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 16, 2026 | 626.92M |
| November 13, 2026 | 657.09M |
| November 12, 2026 | 676.37M |
| November 11, 2026 | 725.81M |
| November 10, 2026 | 699.83M |
| November 09, 2026 | 613.06M |
| November 06, 2026 | 576.58M |
| November 05, 2026 | 515.06M |
| November 04, 2026 | 570.14M |
| November 03, 2026 | 551.54M |
| November 02, 2026 | 519.35M |
| October 30, 2026 | 549.39M |
| October 29, 2026 | 570.85M |
| October 28, 2026 | 581.23M |
| October 27, 2026 | 575.86M |
| October 26, 2026 | 576.58M |
| October 23, 2026 | 583.02M |
| October 22, 2026 | 597.32M |
| October 21, 2026 | 608.77M |
| October 20, 2026 | 637.38M |
| October 19, 2026 | 588.02M |
| October 16, 2026 | 570.85M |
| October 15, 2026 | 620.93M |
| October 14, 2026 | 608.77M |
| October 13, 2026 | 621.65M |
| Date | Value |
|---|---|
| October 12, 2026 | 661.71M |
| October 09, 2026 | 676.73M |
| October 08, 2026 | 664.57M |
| October 07, 2026 | 678.87M |
| October 06, 2026 | 689.60M |
| October 05, 2026 | 724.66M |
| October 02, 2026 | 692.47M |
| October 01, 2026 | 731.81M |
| September 30, 2026 | 744.33M |
| September 29, 2026 | 753.99M |
| September 28, 2026 | 820.51M |
| September 25, 2026 | 784.75M |
| September 24, 2026 | 836.97M |
| September 23, 2026 | 852.71M |
| September 22, 2026 | 917.80M |
| September 21, 2026 | 892.05M |
| September 18, 2026 | 894.20M |
| September 17, 2026 | 909.93M |
| September 16, 2026 | 852.71M |
| September 15, 2026 | 868.44M |
| September 14, 2026 | 873.45M |
| September 11, 2026 | 868.44M |
| September 10, 2026 | 908.50M |
| September 09, 2026 | 880.60M |
| September 08, 2026 | 947.85M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.226B |
| Alnylam Pharmaceuticals, Inc. | 21.38B |
| Anika Therapeutics, Inc. | 173.05M |
| Savara, Inc. | 917.72M |
| Arrowhead Pharmaceuticals, Inc. | 6.246B |
Market Cap Related Metrics
| PEG Ratio | -1.591 |
| Price to Book Value | 1.871 |
| Price | 7.48 |
| Earnings Yield | -11.10% |
| PEGY Ratio | -1.591 |